Showing results (301-310 of 436) with videos related to
Sort By:
Pageof 44
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2012
Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS CohortC Manzardo, A Esteve, N Ortega, et al.Infectious Diseases and Therapy|April 11, 2021
Clinical Characteristics and Outcome of Bloodstream Infections in HIV-Infected Patients with Cancer and Febrile Neutropenia: A Case-Control StudyPedro Puerta-Alcalde, Juan Ambrosioni, Mariana Chumbita, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2026
Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological ProfilesAlberto Foncillas, Juan Ambrosioni, Abiu Sempere, et al.Infectious Diseases and Therapy|May 23, 2026
HBV Serological Profiles and Vaccination Status in People with HIV in the Transition to a Tenofovir-Sparing Era: Insights from a Large HIV CohortAlberto Foncillas, Lorena De La Mora, Leire Berrocal, et al.The Journal of Infection|November 9, 2025
Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial)Juan Ambrosioni, Elisa de Lazzari, Sonsoles Sánchez-Palomino, et al.Mayo Clinic Proceedings|January 8, 2021
Prevalence of Colorectal Neoplasms Among Patients With Enterococcus faecalis Endocarditis in the GAMES Cohort (2008-2017)Juan M Pericàs, Juan Ambrosioni, Patricia Muñoz, et al.JAMA|November 24, 2011
Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failureTodd Kiefer, Lawrence Park, Christophe Tribouilloy, et al.Antimicrobial Agents and Chemotherapy|May 31, 2012
High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditisJosé M Miró, José M Entenza, Ana Del Río, et al.The Journal of Antimicrobial Chemotherapy|December 4, 2025
In vitro exebacase (CF-301) activity against methicillin-susceptible or methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci strains isolated from patients with infective endocarditisMaría-Alexandra Cañas, Guillermo Cuervo, Javier García-González, et al.Journal of the American College of Cardiology|February 4, 2021
Prospective Cohort Study of Infective Endocarditis in People Who Inject DrugsJuan M Pericàs, Jaume Llopis, Eugene Athan, et al.Pageof 44